{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/prescribing-information/high-dose-vitamin-d/","result":{"pageContext":{"chapter":{"id":"13fe48bf-c971-5872-be15-68142508b80a","slug":"high-dose-vitamin-d","fullItemName":"High-dose vitamin D","depth":2,"htmlHeader":"<!-- begin field ddb1c1d0-44b0-4f76-9c35-740801639be2 --><h2>High-dose vitamin D</h2><!-- end field ddb1c1d0-44b0-4f76-9c35-740801639be2 -->","summary":"","htmlStringContent":"<!-- begin item 392cf0c2-875e-42e5-8925-8959faa0cd9b --><!-- end item 392cf0c2-875e-42e5-8925-8959faa0cd9b -->","topic":{"id":"3a69f47b-0066-5318-ba94-a0776d1f423d","topicId":"77754106-b68f-4177-9b0c-fcfcc0541b9a","topicName":"Vitamin D deficiency in adults - treatment and prevention","slug":"vitamin-d-deficiency-in-adults-treatment-prevention","lastRevised":"Last revised in December 2020","chapters":[{"id":"396b28e6-6484-5cca-9444-794f9df7f5ba","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"94588ae1-a24e-565d-9ada-cde0a2e0bb55","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2ca45f23-b265-5722-95e2-d6af017261b5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"e5e6b83a-db43-5cc7-9eb9-cd7edfd8b8bb","slug":"changes","fullItemName":"Changes"},{"id":"a048ffa1-ca03-5795-a6c7-8193bc080874","slug":"update","fullItemName":"Update"}]},{"id":"ea8bab75-416a-570c-906e-886a7bf19f25","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"35b5c184-9d67-5712-b377-e307f07bcb3b","slug":"goals","fullItemName":"Goals"},{"id":"3eba5c68-debd-5037-b81a-cb5e1013a594","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ea5df35b-0a9c-5d62-b0aa-9a555ce5f252","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"38f7be89-95a4-5482-9d9a-f44df577e6da","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"03ca12c7-b5b1-5bee-aa63-4e811d7a3a85","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - options for local implementation"},{"id":"67faf89f-36e5-5dfc-aff0-ccefe829b44e","slug":"nice-quality-standards","fullItemName":"NICE Quality Standards"}]},{"id":"d440bdfb-8a77-5d5a-8d51-42ade33261e5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"311eb939-36fd-5253-ac04-84819593f5d2","slug":"definition","fullItemName":"Definition"},{"id":"c4d9232d-8052-54ae-86f2-4125977b1aa8","slug":"causes","fullItemName":"Causes"},{"id":"837233ab-36b4-51df-9a88-326d3790e336","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"993c0290-b517-5988-be9a-f3ad93c5b0db","slug":"prevalence","fullItemName":"Prevalence"},{"id":"322a14cb-1bf8-5d57-ab4c-efb44f5d7e34","slug":"prognosis","fullItemName":"Prognosis"},{"id":"dac16ea5-b0b9-5165-9ed8-315132d29361","slug":"complications","fullItemName":"Complications"}]},{"id":"99484033-b20e-578b-b849-3a7452cf0ae9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b6fc715d-c19d-53d6-9397-c14378e40e3d","slug":"who-to-test","fullItemName":"Who to test"},{"id":"3a88b9b6-9837-5141-b74f-8167b79b602d","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"17ad9658-809e-5a65-943b-4c7f2a735afb","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"280d7a62-4835-58e6-b17c-7af17719f640","fullItemName":"Management","slug":"management","subChapters":[{"id":"e25197e7-f16f-5181-8e1c-dafe0b580500","slug":"management","fullItemName":"Scenario: Management"},{"id":"0d8d6905-0318-5b5c-88cc-13505f814efa","slug":"prevention","fullItemName":"Scenario: Prevention"}]},{"id":"8ab90bd1-85fe-5075-84fd-a634420ee1dc","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"13fe48bf-c971-5872-be15-68142508b80a","slug":"high-dose-vitamin-d","fullItemName":"High-dose vitamin D"},{"id":"5556b410-0169-5dfa-8b9e-265e042b7ad6","slug":"calcium-supplements","fullItemName":"Calcium supplements"},{"id":"df2f2e94-cfc6-5861-a569-ba2a7e170972","slug":"calcium-vitamin-d-combination-products","fullItemName":"Calcium and vitamin D combination products"}]},{"id":"bbde9f9a-1785-5bb8-accc-6522e50f3da3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a728b337-b5eb-54ce-aa84-fd41e9ab7bfe","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"328964a6-39f5-51ab-b702-b70e97622341","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f8757527-5aee-52e4-927c-3fc956a1a96f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c1c7faf8-f290-5977-8495-18863e441219","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"cfe620c3-2dcb-5d24-a733-8da8eb9076e4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"92307da5-fba2-5898-a234-2e16112ec3c6","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"601d0c22-b19e-50fd-a325-c5d36e5adb83","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"8ab90bd1-85fe-5075-84fd-a634420ee1dc","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"0ac136a3-b9e4-5996-b953-c29eaa6d94e9","slug":"available-preparations","fullItemName":"Available preparations","depth":3,"htmlHeader":"<!-- begin field 416ad878-4c89-4d24-977a-bb4f6d2755fc --><h3>What vitamin D preparations are available to treat vitamin D deficiency or insufficiency?</h3><!-- end field 416ad878-4c89-4d24-977a-bb4f6d2755fc -->","summary":"","htmlStringContent":"<!-- begin item 5893d8ed-0804-44e8-ab67-bc10dd57c3b2 --><!-- begin field 389217eb-b408-406d-bf73-b4af8e0bfc03 --><ul><li><strong>For the treatment of vitamin D deficiency,</strong> there are several high-dose vitamin D preparations available. However, most do not have a UK license.<ul><li>The British National Formulary (BNF) lists the preparations below [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">BNF 72, 2016</a>]:<ul><li>Ergocalciferol (vitamin D<sub>2</sub>) non-proprietary tablets — available in 250 micrograms (10,000 international units [IU] and 1.25 mg (50,000 IU) tablets.</li><li>Ergocalciferol capsules — available in 1.25 mg (50,000 IU) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">ABPI, 2016a</a>].</li><li>Ergocalciferol intramuscular injection containing 7.5 mg (300,000 IU) of vitamin D<sub>2 </sub>per mL —available in 1 and 2 mL ampoules.</li><li>Fultium-D3<sup>®</sup> (colecalciferol) capsules — available in 80 micrograms (3200 IU) and 500 micrograms (20,000 IU) capsules.</li><li>InVita D3® (colecalciferol) oral solution — available in 625 micrograms (25,000 IU) per mL ampoules. </li></ul></li><li>Detailed information on these products is available in the BNF (<a data-hyperlink-id=\"d276e8de-f0dd-4a7e-8be8-a992013f282f\" href=\"http://www.evidence.nhs.uk/\">www.evidence.nhs.uk</a>) and the manufacturers’ Summaries of Product Characteristics (SPCs, <u><a data-hyperlink-id=\"f7f555e8-82cd-4eed-bf65-a992013f2864\" href=\"http://www.medicines.org.uk/emc/\">www.medicines.org.uk</a></u>).</li></ul></li><li><strong>For the treatment of vitamin D insufficiency:</strong><ul><li>The BNF lists the following preparations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">BNF 72, 2016</a>]:<ul><li>Fultium-D3<sup>®</sup> (colecalciferol) 20 micrograms (800 IU) capsules.</li><li>Desunin<sup>®</sup> (colecalciferol) tablets — available in 20 micrograms (800 IU) and 100 micrograms (4,000 IU). </li></ul></li><li>There are no products containing maintenance doses of ergocalciferol alone.</li></ul></li><li><strong>Unlicensed formulations of vitamin D preparations are available from 'special-order' manufacturers and specialist importing companies.</strong><ul><li>The East and South East England Specialist Pharmacy Services document <a data-hyperlink-id=\"2da0aa8b-f345-4a35-ac3a-a992013f28fc\" href=\"https://www.sps.nhs.uk/wp-content/uploads/2014/08/fileMDs3Nzg2ODU7L3VwbG9hZC9kb2N1bWVudHMvQ29tbXVuaXRpZXMvU1BTX0VfU0VfRW5nbGFuZC9WaXRhbWluIEQgcHJvZHVjdCBhdmFpbGFiaWxpdHkgQXVnIDIwMTQucGRm.pdf\">Vitamin D deficiency and Insufficiency: using appropriate available products</a> has a comprehensive (but not exhaustive) list of available vitamin D products, including unlicensed products.</li></ul></li><li><strong>For people with peanut or soya allergy,</strong> see the UK Medicines Information (UKMi) document <a data-hyperlink-id=\"3189384f-3fcf-45c7-9290-a992013f2925\" href=\"https://www.sps.nhs.uk/articles/is-there-a-suitable-vitamin-d-product-for-a-patient-with-a-peanut-or-soya-allergy/\">Is there a suitable vitamin D product for a patient with a peanut or soya allergy?</a>, available on the NICE Evidence website (<a data-hyperlink-id=\"a52e644f-5ddc-4ea5-b60e-a992013f293c\" href=\"http://www.evidence.nhs.uk/search?q=%22Is+there+a+suitable+vitamin+D+product+for+a+patient+with+a+peanut+or+soya+allergy%22\">www.evidence.nhs.uk</a>), for information on suitable peanut and soya-free vitamin D preparations.</li><li><strong>For people on a vegetarian or vegan diet,</strong> see the UKMi document <a data-hyperlink-id=\"2fa5a707-68e1-4b5f-ac7f-a992013f29ee\" href=\"https://www.sps.nhs.uk/articles/which-vitamin-d-preparations-are-suitable-for-a-vegetarian-or-vegan-diet/\">Which vitamin D preparations are suitable for a vegetarian or vegan diet?</a> for infomation on suitable preparations.</li><li><strong>For people with halal or kosher requirements,</strong> the UKMi document <a data-hyperlink-id=\"d000f44f-7aa7-4c56-b7f8-a992013f2a58\" href=\"https://www.sps.nhs.uk/articles/which-vitamin-d-preparations-are-suitable-for-a-vegetarian-or-vegan-diet/\">Which vitamin D preparations are suitable for a vegetarian or vegan diet?</a> has some information on halal and kosher compliant vitamin D products.</li></ul><!-- end field 389217eb-b408-406d-bf73-b4af8e0bfc03 --><!-- end item 5893d8ed-0804-44e8-ab67-bc10dd57c3b2 -->","subChapters":[]},{"id":"8a2b8c65-cab8-534f-a590-3959b1cf7d8f","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 7fefcf38-9abd-427a-bd78-b020dad5d8bd --><h3>What are the contraindications and cautions for vitamin D?</h3><!-- end field 7fefcf38-9abd-427a-bd78-b020dad5d8bd -->","summary":"","htmlStringContent":"<!-- begin item e3739c50-51ad-4a59-8847-95e26f22be87 --><!-- begin field b0224d41-c427-4d23-9126-a33d1a24662a --><ul><li><strong>Do not prescribe vitamin D preparations to people with:</strong><ul><li>Hypercalcaemia or hypercalciuria (or diseases or conditions which can cause these problems).</li><li>Metastatic calcification.</li><li>Hypervitaminosis D.</li><li>Nephrolithiasis.</li><li>Severe renal impairment — vitamin D<sub>3</sub> and D<sub>2 </sub>are not metabolized normally; other forms of vitamin D should be used.</li></ul></li><li><strong>Prescribe vitamin D with caution to:</strong><ul><li>People with mild to moderate renal impairment.</li><li>People with a co-existing condition associated with increased sensitivity to vitamin D (such as sarcoidosis, tuberculosis, lymphoma, or primary hyperparathyroidism) — consider seeking specialist advice.</li><li>Pregnant women — consider seeking specialist advice. </li><li>Breastfeeding women (due to the risk of hypercalcaemia in the infant).</li><li>People taking <a class=\"topic-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/prescribing-information/high-dose-vitamin-d/#drug-interactions\">certain drugs</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">ABPI, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">BNF 72, 2016</a>] </p><!-- end field b0224d41-c427-4d23-9126-a33d1a24662a --><!-- end item e3739c50-51ad-4a59-8847-95e26f22be87 -->","subChapters":[]},{"id":"b4e026fe-fda6-5893-abb0-2341bfa59323","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 62076666-ab93-416f-8735-af0175ed7b1c --><h3>What are the adverse effects of vitamin D?</h3><!-- end field 62076666-ab93-416f-8735-af0175ed7b1c -->","summary":"","htmlStringContent":"<!-- begin item 65abcd39-92d8-428c-b18a-6d4961bdbca8 --><!-- begin field c25b998d-9060-4f10-ae21-7d67f34b648e --><ul><li><strong>Vitamin D toxicity (which rarely occurs unless the vitamin D dose is very high) manifests mainly through chronic hypercalcaemia, </strong>leading to deposition of calcium in soft tissues, diffuse mineralization of bone, and irreversible renal and cardiovascular toxicity.<ul><li><strong>The clinical features of hypercalcaemia include:</strong></li><li>Nausea and vomiting.</li><li>Diarrhoea.</li><li>Constipation.</li><li>Anorexia and weight loss.</li><li>Lethargy.</li><li>Polyuria and thirst.</li><li>Sweating.</li><li>Headache.</li><li>Vertigo.</li><li>Raised concentrations of calcium and phosphate in plasma and urine.</li></ul></li><li><strong>If hypercalcaemia is suspected, </strong>check serum calcium levels. If hypercalcaemia is identified:<ul><li>Assess the person's state of hydration, and consider admission if the person is dehydrated.</li><li>If the person is taking a calcium supplement, advise that it should be stopped.</li></ul></li><li><strong>Other adverse effects that have been linked with high vitamin D intakes or high serum 25-hydroxyvitamin D (25 [OH]D) concentrations include</strong> an increased incidence of falls and fractures, an increased rates of pancreatic and prostate cancer, and increased total mortality (that is, from all causes combined). However, evidence for these associations is less robust and consistent than that relating to hypercalcaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">SACN, 2016</a>].</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">BNF 72, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">SACN, 2016</a>]</p><!-- end field c25b998d-9060-4f10-ae21-7d67f34b648e --><!-- end item 65abcd39-92d8-428c-b18a-6d4961bdbca8 -->","subChapters":[]},{"id":"40fa89af-ba1e-57ec-a3b6-a437e54a7448","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 4914330b-6297-4d4c-a1f7-2a30b49fe7e0 --><h3>What drug interactions are associated with vitamin D?</h3><!-- end field 4914330b-6297-4d4c-a1f7-2a30b49fe7e0 -->","summary":"","htmlStringContent":"<!-- begin item 79097004-0c13-4471-ba5a-0960bf81aaf4 --><!-- begin field e8b0225c-e1a4-48e6-ace8-1dcbeffa18bc --><ul><li><strong>The key drug interactions associated with vitamin D are listed below. </strong>Seek specialist advice as appropriate during concurrent treatment with these drugs.<ul><li><strong>Antiepileptic drugs (phenytoin or barbiturates) </strong>— can increase the metabolism of vitamin D, leading to a reduction in the effects of vitamin D.<ul><li>Higher doses of vitamin D may be needed.  </li></ul></li><li><strong>Cardiac glycosides</strong> — excessive dosing of vitamin D can induce hypercalcaemia, which may enhance the effects of digoxin and other cardiac glycosides (leading to an increased risk of digoxin toxicity and serious arrhythmias).<ul><li>Close monitoring (and possibly a dose reduction of vitamin D) is needed during concurrent use.</li></ul></li><li><strong>Corticosteroids </strong>— may increase vitamin D metabolism and elimination.<ul><li>Higher doses of vitamin D may be needed. </li></ul></li><li><strong>Ion exchange resins (such as colestyramine) or laxatives (such as paraffin oil) </strong>— may reduce the gastrointestinal absorption of vitamin D.<ul><li>Higher doses of vitamin D may be needed.  </li></ul></li><li><strong>Miconazole </strong>— the effects of vitamin D are possibly reduced by miconazole.<ul><li>Higher doses of vitamin D may be needed.  </li></ul></li><li><strong>Orlistat </strong>— may prevent the absorption of vitamin D, even in people also taking multivitamins.<ul><li>Advise that vitamin D preparations should be taken at least 2 hours after taking orlistat. It may be necessary to monitor vitamin D levels, even if multivitamins are given [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">Preston, 2015</a>].</li></ul></li><li><strong>Thiazide diuretics</strong> <strong>(such as bendroflumethiazide) </strong>— may reduce the urinary excretion of calcium thereby increasing the risk of hypercalcaemia.<ul><li>Close monitoring (and possibly a dose reduction of vitamin D) is needed during concurrent use. </li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">ABPI, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/references/\">BNF 72, 2016</a>]</p><!-- end field e8b0225c-e1a4-48e6-ace8-1dcbeffa18bc --><!-- end item 79097004-0c13-4471-ba5a-0960bf81aaf4 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}